540 results on '"Patrignani, Paola"'
Search Results
152. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo
153. De Novo Synthesis of Cyclooxygenase-1 Counteracts the Suppression of Platelet Thromboxane Biosynthesis by Aspirin
154. Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A2–Dependent Prostaglandin E2 Generation in Human Colorectal Cancer Cells
155. Clinical pharmacology of etoricoxib
156. New insights into COX-2 biology and inhibition
157. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
158. Isoprostanes and other markers of peroxidation in atherosclerosis
159. Novel Synthesis of 3,4-Diarylisoxazole Analogues of Valdecoxib: Reversal Cyclooxygenase-2 Selectivity by Sulfonamide Group Removal
160. Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects
161. Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis
162. Preface [Hot topic: New Insights into COX-2 Biology and Inhibition (Executive Editor: Paola Patrignani)]
163. Lumiracoxib
164. Determinants of Platelet Activation in Human Essential Hypertension
165. Cox2 and MDR-1 Pg-P expression in gastric mucosa: A molecular pathway of Helicobacter pylori related- gastric carcinogenesis
166. Clinical pharmacology of etoricoxib: a novel selectiveCOX2 inhibitor
167. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells
168. Modulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable Angina
169. Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor
170. Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease
171. Enhaced cortisol secretion does not control aspirin-insensitivess thromboxane biosynthesis in patients with acute coronary syndromes
172. The Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity
173. New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia
174. Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina
175. Effects of Vitamin E Supplementation on F 2 -Isoprostane and Thromboxane Biosynthesis in Healthy Cigarette Smokers
176. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer
177. Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable Angina
178. Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases
179. Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation
180. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2, 4-difluorothiophenyl)-1-indanone (L-745, 337), on the cyclo-oxygenase activity of human blood prostaglandin
181. Effects of nabumetone on prostanoid biosynthesis in humans*
182. Rare SNP rs12731181 in the miR-590-3p Target Site of the Prostaglandin F2αReceptor Gene Confers Risk for Essential Hypertension in the Han Chinese Population
183. Characterization of Biochemical and Functional Effects of Antiplatelet Drugs as a Key to Their Clinical Development
184. Eicosanoid Biosynthesis and Metabolism in Myeloproliferative Disorders
185. Synthesis,Pharmacological Characterization, and DockingAnalysis of a Novel Family of Diarylisoxazoles as Highly Selective Cyclooxygenase-1 (COX-1) Inhibitors.
186. Release of Contracting Autacoids by Aortae of Normal and Atherosclerotic Rabbits
187. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study.
188. Managing the adverse effects of nonsteroidal anti-inflammatory drugs.
189. Variability Among Nonsteroidal Antiinflammatory Drugs in Risk of Upper Gastrointestinal Bleeding.
190. Calcium mobilization and right-angle light scatter responses to 12-oxo-derivatives of arachidonic acid in neutrophils: evidence for the involvement of the leukotriene B4 receptor
191. Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-a Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells.
192. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease*.
193. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease*.
194. Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole Mood
195. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease
196. The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids*.
197. Eicosanoid Biosynthesis and Metabolism in Myeloproliferative Disordersa.
198. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings*.
199. Effects of nabumetone on prostanoid biosynthesis in humans*.
200. Effects of sulindac on renal and extrarenal eicosanoid synthesis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.